Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart watches could revolutionize knee arthritis monitoring

NCT ID NCT07031518

Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Liege Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested whether wearable sensors (Syde devices) can reliably track knee osteoarthritis symptoms at home over two months. 43 participants wore the sensors on their ankles and wrists to record movement data, which was compared with standard clinic tests. The goal was to identify digital biomarkers that could improve treatment evaluation and personalized care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Syde wearable device (watch-like sensors)
What this could lead to
If successful, this could lead to more accurate, home-based monitoring of knee osteoarthritis, improving how treatments are evaluated and personalized.
What could go wrong
This is a small pilot study with only 43 participants, so results may not apply broadly. The device's reliability and usefulness need further validation in larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

43 people

The number who actually took part.

Started

May 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with bi- or unilateral Knee Osteoarthritis as confirmed by a qualified rheumatologist/orthopaedist or rehabilitation doctor and having had at least one X-ray or MRI for diagnosis confirmation with Kellgren-Lawrence grade minimum 1 * WOMAC 3.1 total score at screening indicating mild, moderate, or severe symptoms in the past 48 hours * BMI below 35.0 kg/m2 Exclusion Criteria: * Patients with significant cognitive disorders, limiting the understanding of the exercises to be performed or the presence of apparent communication difficulties hindering the correct collection of data. * Unable to walk independently (10 meters without any type of external help) * History of any joint replacement surgery. * Currently undergoing or had corticosteroid injections within the past 3 weeks. * Underwent knee surgery in the past 6 months. * Expecting joint replacement surgery or arthroscopy within 3 months. * Pregnant women or women planning to become pregnant during the study * Presence of any other conditions than osteoarthritis (musculoskeletal or neurological) that may affect normal gait. OA in other joints is not considered as an exclusion criterion as long as OAK is the most significant cause of walking impairment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Osteoarthritis of the knee are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Osteoarthritis of the knee

Contacts and locations

Locations

  • Centre de référence des maladies neuromusculaire (CRMN Liège), Hopital de la Citadelle

    Liège, 4000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.